ArticleChemMedChem2026

In Vitro Evaluation of PARP1 Inhibitor Olaparib-Cyanine Dye Conjugate for the Treatment of Glioblastoma.

Carina Dumo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.